Trial no.:
|
PACTR201908766157563 |
Date of Approval:
|
16/08/2019 |
Trial Status:
|
Registered in accordance with WHO and ICMJE standards |
|
TRIAL DESCRIPTION |
Public title
|
Role of Rebound Therapy in the Rehabilitation of Children with Spastic Cerebral Palsy
|
Official scientific title |
Role of Rebound Therapy in the Rehabilitation of Children with Spastic Cerebral Palsy |
Brief summary describing the background
and objectives of the trial
|
Cerebral palsy (CP) is a group of disorders of movement and posture, causing several body impairments. CP is caused by non-progressive disturbance that occurred in the fetal or immature brain. CP symptoms include several motor disorders such as disturbances in sensation, coordination, cognition, communication and behavior in addition to disturbances in postural stability, balance and coordination (Shevell, 2018; Liao and Hwang, 2011).
Balance is the ability to maintain the center of body mass over the base of support. CP causes balance impairment which results in decrease in the child’s mobility functions and causing activity limitation and participations restrictions (Laforme Fiss et al., 2019).
Motor coordination is the registration of two or more things such as body movements , timing or sensory feedback into a harmonious relationship (Cordo and Gurfinkel, 2004). CP causes disturbances in motor coordination such as difficulties in the routine gross movements as running and jumping, and disturbances in common fine movements like buttoning, clothing or brushing hair (Payne and Isaacs, 2012).
Rebound therapy is an exercise therapy which uses mini trampolines, rebounders , Springfree Trampoline and Swiss balls, to provide opportunity to perform recreational movements for individuals with different body structural and functional impairments (Rebound therapy Association, 2019)
Purposes of the Study:
To evaluate the effect of rebound therapy on gross motor function, balance and gross motor coordination in children with spastic cerebral palsy.
|
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
Nervous System Diseases |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Treatment: Other |
Anticipated trial start date |
05/08/2019 |
Actual trial start date |
|
Anticipated date of last follow up |
30/06/2021 |
Actual Last follow-up date |
|
Anticipated target sample size (number of participants) |
32 |
Actual target sample size (number of participants) |
32 |
Recruitment status |
Active, not recruiting |
Publication URL |
|
|